Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Colonization with extended-spectrum and AmpC β-lactamase-producing Enterobacterales and bacteremia risk in patients with acute leukemia who receive induction chemotherapy without fluoroquinolone prophylaxis.
Journal: Antimicrobial agents and chemotherapy
Published: June 26, 2026
Immunogenicity of COVID-19 mRNA vaccines in patients with acute myeloid leukemia and myelodysplastic syndrome.
Journal: Leukemia & lymphoma
Published: October 25, 2022
Herpes Simplex Virus Hepatitis in an Immunocompetent Host Resembling Hepatic Pyogenic Abscesses.
Journal: Case reports in hepatology
Published: July 14, 2016
Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease.
Journal: The Journal of antimicrobial chemotherapy
Published: March 11, 2016
Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease.
Journal: The Journal of antimicrobial chemotherapy
Published: June 12, 2015
Phase 1b study of new posaconazole tablet for prevention of invasive fungal infections in high-risk patients with neutropenia.
Journal: Antimicrobial agents and chemotherapy
Published: July 23, 2014
Septic shock caused by Klebsiella pneumoniae carbapenemase-producing Enterobacter gergoviae in a neutropenic patient with leukemia.
Journal: Journal of clinical microbiology
Published: June 14, 2013
Emergence of carbapenem-resistant Enterobacteriaceae as causes of bloodstream infections in patients with hematologic malignancies.
Journal: Leukemia & lymphoma
Published: August 25, 2012
Pharmacokinetics of different dosing strategies of oral posaconazole in patients with compromised gastrointestinal function and who are at high risk for invasive fungal infection.
Journal: Antimicrobial agents and chemotherapy
Published: February 01, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026